Catalent : Launches New Oral Developability Assessment and Manufacturing Solution to Advance Targeted Protein Degrader Programs

SOMERSET, N.J. - March 29, 2023 - Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced the... | March 29, 2023

Related Keywords

New Jersey ,United States ,Germany ,Beinheim ,Alsace ,France ,North Carolina ,California ,Florida ,Kentucky ,Greenville ,Petersburg ,Sankt Peterburg ,Russia ,San Diego ,Missouri ,Schorndorf ,Bayern ,Julien Meissonnier , ,Proteosuite Oral ,Vice President ,Chief Scientific ,Kansas City ,Catalent ,Nc Stock Exchange ,News ,Information ,Press Release ,Arch ,023 ,The ,Leader ,N ,Nabling ,Development ,End ,Supply ,F ,Setter ,Treatments ,Or ,Patients ,Oday ,Nnounced Ctlt Us1488061029 ,